Discover 1,482 paid clinical trials in Greeley, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,482
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks
for
Acute Hereditary Angio Edema
Location: Centennial CO
Sponsor: Octapharma
Sex: All
Age: 2+
Code: NCT06361537
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Investigating the Neural Systems That Support the Reappraisal Tactics Leading to Positive Emotion
for
Behavior
Location: Denver CO
Sponsor: University of Denver
Sex: All
Age: 18 - 55
Code: NCT04532242
Recruiting
Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance
for
Impaired Glucose Tolerance
Location: Denver CO
Sponsor: Denver Research Institute
Sex: All
Age: 25 - 70+
Code: NCT00733174
Recruiting
Effects of Binaural Beats and Spatialized Music on Behavioural and Psychological Symptoms of Dementia in Assisted Living Facility Residents
for
BPSD, Caregiver Distress, Well-being, Mood
Location: Denver CO, Lakewood CO
Sponsor: Maharishi International University
Sex: All
Age: 55 - 70+
Code: NCT07626944
Recruiting
Parenting in 2 Worlds Multisite Trial
for
Parenting, Mental Health Wellness 1, Substance Use,
Location: Denver CO, Phoenix AZ, Saint Paul MN, Buffalo NY
Sponsor: Arizona State University
Sex: All
Age: 12+
Code: NCT06324318
Phase 2, Recruiting
Knee Related Subchondral Bone Lesions Treated With IOBP
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Aurora CO, Santa Fe NM, Omaha NE, Waukee IA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06943872
Phase 3, Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
for
Leukemia, Myeloid, Acute
Location: Aurora CO, Salt Lake City UT, Jupiter FL, Goodyear AZ,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06852222
Phase 3, Recruiting
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
for
Urothelial Cancer, Urinary Bladder Neoplasms
Location: Aurora CO, Columbia MO, Tyler TX, Austin TX,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07566156
Phase 3, Recruiting
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
for
CLL, Chronic Lymphocytic Leukemia
Location: Aurora CO, Golden CO, Billings MT, Omaha NE,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06846671
Phase 3, Recruiting
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
for
Chronic Lymphocytic Leukemia
Location: Aurora CO, Salt Lake City UT, Omaha NE, Rochester MN,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07277231
Phase 3, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Aurora CO, Grand Junction CO, Murray UT, Amarillo TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase 2, Recruiting
Featured
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
for
Multiple Myeloma
Location: Denver CO, Salt Lake City UT, Dallas TX, Duarte CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06892522
Phase 1, Phase 2, Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Aurora CO, Wichita Falls TX, Tyler TX, Peoria IL,
Sponsor: BioNTech SE
Sex: Male
Age: 18+
Code: NCT07365995
Phase 3, Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer